Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Reiley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|October 22, 2004
Negative regulation of JNK signaling by the tumor suppressor CYLDWilliam Reiley, Minying Zhang, Shao-Cong Sun
The Journal of Biological Chemistry|January 13, 2005
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathwayMatthew D Morrison, William Reiley, Minying Zhang, et al.
Molecular and Cellular Biology|May 5, 2005
Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylationWilliam Reiley, Minying Zhang, Xuefeng Wu, et al.
Molecular and Cellular Biology|June 17, 2004
IkappaB kinase is an essential component of the Tpl2 signaling pathwayMichael Waterfield, Wei Jin, William Reiley, et al.
Immunological Reviews|October 8, 2008
Early T-cell responses in tuberculosis immunityGary M Winslow, Andrea Cooper, William Reiley, et al.
The Journal of Clinical Investigation|April 3, 2008
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in miceWei Jin, Mikyoung Chang, Emmanuel M Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infectionKatrin D Mayer, Katja Mohrs, William Reiley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Mouse Models Uniformly Featuring Human-like Lesions Harboring Drug-tolerant <i>Mycobacterium tuberculosis</i>Gaëlle Guiewi Makafe, Tim Low-Beer, Kelsey Travis, et al.
Infection and Immunity|February 9, 2026
Mouse models of tuberculosis uniformly featuring hypoxic necrotic lesions and poor response to chemotherapyGaëlle Guiewi Makafe, Tim Low-Beer, Kelsey Travis, et al.
Science (New York, N.Y.)|January 20, 2018
Genome-wide identification of interferon-sensitive mutations enables influenza vaccine designYushen Du, Li Xin, Yuan Shi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|October 22, 2004
Negative regulation of JNK signaling by the tumor suppressor CYLDWilliam Reiley, Minying Zhang, Shao-Cong Sun
The Journal of Biological Chemistry|January 13, 2005
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathwayMatthew D Morrison, William Reiley, Minying Zhang, et al.
Molecular and Cellular Biology|May 5, 2005
Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylationWilliam Reiley, Minying Zhang, Xuefeng Wu, et al.
Molecular and Cellular Biology|June 17, 2004
IkappaB kinase is an essential component of the Tpl2 signaling pathwayMichael Waterfield, Wei Jin, William Reiley, et al.
Immunological Reviews|October 8, 2008
Early T-cell responses in tuberculosis immunityGary M Winslow, Andrea Cooper, William Reiley, et al.
The Journal of Clinical Investigation|April 3, 2008
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in miceWei Jin, Mikyoung Chang, Emmanuel M Paul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2008
Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infectionKatrin D Mayer, Katja Mohrs, William Reiley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Mouse Models Uniformly Featuring Human-like Lesions Harboring Drug-tolerant <i>Mycobacterium tuberculosis</i>Gaëlle Guiewi Makafe, Tim Low-Beer, Kelsey Travis, et al.
Infection and Immunity|February 9, 2026
Mouse models of tuberculosis uniformly featuring hypoxic necrotic lesions and poor response to chemotherapyGaëlle Guiewi Makafe, Tim Low-Beer, Kelsey Travis, et al.
Science (New York, N.Y.)|January 20, 2018
Genome-wide identification of interferon-sensitive mutations enables influenza vaccine designYushen Du, Li Xin, Yuan Shi, et al.
Pageof 2